caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1326251299

Shannon Huggins-PuhallaMD

PRACTICEMAGEE WOMENS HOSPITALSee all providers at this practice →
Medical OncologyPittsburgh, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (5)

CCN 390073
Hospital
CCN 390091
Hospital
CCN 390107
Hospital
CCN 390114
Hospital
CCN 390164
Hospital
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
322
Unique beneficiaries
—
Total services
583
Distinct HCPCS
5
Medicare payment
$44K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 199 Medical Oncology providers in PA — below median (cohort median 620).
REFERRAL NETWORK

Where Shannon Huggins-Puhalla's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 6 outbound destinations.

Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
UPMC MAGEE-WOMENS HOSPITAL111731
UPMC PRESBYTERIAN SHADYSIDE21114
Adam Brufsky
Medical Oncology · Pittsburgh, PA
1971
Quest Diagnostics Venture Llc
Clinical Laboratory · Pittsburgh, PA
1751
Dilip Shinde
Diagnostic Radiology · Pittsburgh, PA
1687
Christiane Hakim
Diagnostic Radiology · Pittsburgh, PA
1227
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
1,400
Beneficiaries
—
Total drug cost
$2.5M
Distinct drugs
22
Brand share
14.1%
Top prescribed drugs
Anastrozole683 claims
Letrozole174 claims
Exemestane59 claims
Ondansetron Hcl51 claims
Abemaciclib42 claims
QUALITY · MIPS · 2024
Final MIPS score
64.8
Quality
42.5
Cost
76.2
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
-1.22%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$8K
Payment records
11
By payment type
Consulting Fee$7K
Travel and Lodging$712
Food and Beverage$429